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The murine  17th chromosome contains two regions of particular interest to biolo- 
gists, the  Tit complex and the major histocompatibility complex (MHC). 1 The T/t 
complex controls  a  number  of loci  that  have  important  functions  in  embryonic 
development  (1);  the  MHC  encodes  gene  products  that  are  involved  in  cellular 
interactions critical for immune function (2). A third region, Tla, located telomeric to 
H-2D  (3),  has  recently been  described.  The  Tla  region  controls the  expression of 
several serologically defined lymphoid cell surface alloantigens termed TL and Qa 
antigens  (3).  At  present,  five Qa  antigens  (Qa-l-5)  have been  described  and  the 
expression of these antigens appears to be confined primarily to hematopoietic cells 
(4-7). Earlier studies (3-12) indicated that Qa antigens were found predominantly on 
T  cells but that Qa-1, Qa-2, Qa-3, and Qa-4 are expressed on mitogen-stimulated B 
cells as well.  More  recent studies  have demonstrated  that  Qa-2  is  expressed on  a 
variety of hematopoietic cells, including subsets of B cells, myeloid progenitor cells, 
and multipotential stem cells (13). In addition, Qa-4 and Qa-5 antigens are expressed 
on natural killer cells (14). 
Antisera  recognizing Qa-1  or Qa-2  antigens  define cell surface glycoproteins of 
44,000  mol wt  that  are  noncovalently associated with 8-2  microglobulin  (lfi,  16). 
Thus, Qa-1  and Qa-2 may be related to H-2 alloantigens at the primary structural 
level. 
In  the  present  report,  we  describe  studies  of the  Qa-2  antigen  at  the  primary 
structural level. Isotopically labeled Q a-2, H-2K, and H-2D antigens from lysates of 
mitogen-stimulated  C57BL/6  spleen cells were immunoprecipitated with  congenic 
alloantisera. Comparative mapping of the tryptic peptides obtained from Qa-2 and 
H-2 molecules indicate that  these two molecules have different primary structures, 
but that there is considerable structural homology between them. The data suggest, 
therefore, that  the genes encoding the Qa-2  and  H-2 molecules have arisen from a 
common primordial gene. 
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Materials and Methods 
Mice.  Adult mice, 6-10 wk of age, were used in these experiments. C57BL/6 mice (B6) 
were purchased from The Jackson Laboratory, Bar Harbor, Maine. The B10.A and B6.K1 
strains were inbred strains obtained from the colony maintained at The University of Texas 
Health Science Center at Dallas. 
Antisera.  Antisera reactive against Qa-2 were prepared by immunizing B6.K1  mice with 
B6 spleen and lymph node cells as described previously (6). The [B10.A (5R)  ×  R III]F1 a B10 
antiserum (aD  b) was obtained from the Research Resources Branch of the National Institutes 
of Health, Bethesda, Md. All other anti H-2 alloantisera were prepared by immunizing the 
appropriate recipients with donor spleen and lymph node cells as described in Table I. Anti-H- 
2D vs. anti-H-2K activity was determined by immunoprecipitation analysis of lysates from 
spleens of appropriate recombinant mice. Rabbit anti-mouse immunoglobulin (RAMIg) and 
goat  anti-mouse immunoglobulin (GAMIg) were prepared as described previously (17,  18). 
Normal mouse serum  (NMS;  Pel-Freeze Biologicals Inc., Rogers, Ariz.)  was obtained from 
outbred mice. 
Preparation and Labeling of Mitogen-activated Spleen Cells.  Mouse spleens were teased into Hanks' 
balanced salt solution (HBSS) and single cell suspensions  were prepared as described previously 
(19). Cell viability  was assessed using trypan blue exclusion. Concanavalin  A (Con A)-aetivated 
spleen cells were routinely prepared by resuspending 7.2 ×  10  s viable cells in 200 ml RPMI- 
1640 containing 5% fetal calf serum (FCS), 5 pg/ml Con A  (ICN Nutritional Bioehemicals, 
Cleveland, Ohio),  5  ×  10  -s M  2-mercaptoethanol (2-ME),  glutamine, and antibiotics. To 
s  obtain lipopolysaccharide (LPS)-activated cells, 3 ×  I0  viable spleen cells were resuspended in 
150 ml RMPI-1640 containing 20% FCS, 5 ×  10  -5 M 2-ME, 2× nonessential amino acids and 
glutamine, 1 mM sodium pyruvate, 50 #g/ml LPS (Salmonella typhosa 0901; Difco Laboratories, 
Detroit, Mich.), and antibiotics. The cultures were then gassed with 10% CO2 and incubated 
for 48 h at 37°C. 
The mitogen-activated cells were harvested and labeled at 1 ×  l0  T  cells/ml for 8 h with aH 
(150  /xCi/ml)  or  t4C  (15  /~Ci/ml)  amino acids  (New  England Nuclear,  Boston,  Mass.  or 
Amersham-Searle Corp., Arlington Heights, Ill.) as detailed elsewhere (20). Labeled cells were 
harvested by centrifugation, washed twice in Tris-buffered saline (TBS), pH 7.4, and lysed for 
15 rain at 4°C in 5-6 ml TBS containing  0.5% nonidet P-40 (NP-40; Gallard, Schlesinger, New 
York).  Nuclei and debris were subsequently removed by centrifugation for  15 rain at 2,000 g. 
TABLE  I 
Description of H-2 AUoantisera 
Strains used for 
H-2 haplotypes*  immunoprecipita-  H-2 al- 
Antise-  tion 
rum des-  Recipient/donor combination  loantigen  recog- 
ignation  I  I  nized 
K  ABJEC  SD  (K  ABJEC  SD) 
otD  b  Recipient: [B10.A(5R) × RIII]Fa  b  bbkkd  d d  B6  D  b 
r  rrrrr  r  r  Co  bbbbb  bb) 
Donor:Bl0  b  bbbbb  bl~ 
aK  b  Recipient: [B10,D2 × A/J]F1  d  ddddd  d d  B6  K  b 
k  kkkkd  dd  Co  bbbbb  bb) 
Donor:B10.A(5R)  b  bbkkd  dd 
aD  d  Recipient:B10.BR  k  kkkkk  kk  B10.A  D  a 
(k  kkkkd  dd) 
Donor:Bl0.D2  d  ddddd  dd 
aK  ~  Recipient: [BALB/cKh × B10.D2]FI  d  ddddd  d d  B 1 0 .A  K  k 
d  ddddd  dd  (k  kkkkd  dd) 
Donor:BI0.BR  k  kkkkk  kk 
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Immunopredpitation and Isolation of  H-2K, H-2D, and Qa-2 Molecules.  Glycoproteins  were isolated 
from NP-40 lysates of labeled cells by fractionation on Lentil-lectin Sepharose (20). Lentil-lectin 
was purified from  Lens culinaris and  coupled to Sepharose 4B  as described previously (21). 
Lysates were applied to the lectin column in TBS containing 0.25% NP-40 and the nonadherent 
proteins were eluted in  the same buffer.  The  adherent  material was eluted with 0.3  M  a- 
methylmannoside in TBS with 0.25%  NP-40, and concentrated to ~5 ml by negative-pressure 
dialysis. 
The  concentrated  glycoprotein  pools  were  centrifuged  at  10,000  g  for  15  rain  before 
immunoprecipitation. Immunoglobulin was immunoprecipitated from the concentrated gly- 
coprotein pool by incubation with RAMIg (300 #1/3 ×  l0  s cells) for 15 min at 37°C and 30 
min at 4°C. Immune complexes were removed by the addition of protein A-bearing Cowan I 
strain of Staphylococcus aureus, followed by incubation for  15 min at 37°C  and 30 min at 4°C 
(22). Immunoglobulin-depleted glycoprotein pools were then depleted of"nonspecific" material 
by adding NMS (250#1/3 ×  10° cells) for 15 rain at 37°C and 30 rain at 4°C, followed by two 
treatments with S. aureus. "Preeleared" glycoprotein pools were then reacted with the appro- 
priate alloantisera at 37°C for 15 min and 4°C for 2-12 h. All alloantisera were titered so as to 
remove all reactive molecules. Immune complexes were removed by either immunoprecipitating 
them with GAMIg or by absorbing them to S. aureus. Immunoprecipitates or S. aureus-bound 
complexes were washed three times with TBS containing 0.1% sodium dodecyl sulfate (SDS), 
0.25% NP-40, and 0.2%  deoxycholate, followed by one wash with TBS.  Immune complexes 
were eluted from the S. aureus or immune precipitates were dissolved by boiling for 2 min in 
electrophoresis sample buffer with 5% 2-ME. All insoluble material was removed by centrifu- 
gation at 10,000 g for 5 rain. Samples were electrophoresed for 4-5 h on 12.5% polyacrylamide 
gels  using  the  Laemmli  discontinuous  system  as  described  previously  (23).  All gels  were 
fractionated using a  Savant gel crusher (Savant Instruments Inc., Hicksville, N. Y.). In some 
experiments, gels were fractionated directly into scintillation vials and then counted in Beckman 
EP cocktail (Beckman Instruments Inc., Fullerton, Calif.). Alternatively, the fractionated gels 
were incubated overnight in 0.01%  SDS to allow the radiolabeled protein to elute from the gel 
matrix. Aliquots of each fraction were then removed and counted in scintillation cocktail. The 
appropriate fractions were  pooled, gel pieces were  removed by filtration through  a  0.45-# 
Millipore filter (Millipore Corp., Bedford, Mass.), and the samples were then lyophilized. 
Preparation and Use of Sepharose-GAMlg.  GAMIg serum (10) was affinity-purified on Sepha- 
rose-mouse euglobulin and coupled at 1 mg/ml to cyanogen-activated Sepharose 4B (24). 
Trypsin Digestion and  Comparative Peptide Mapping.  The  techniques  described below have 
been detailed elsewhere (25, 26). Lyophilized H-2D, H-2K, or Qa-2 molecules were redissolved 
in 2-3 ml dH20 containing 0.5-1.0 mg human gammaglobulin (HGG) as carrier and dialyzed 
against several changes of 0.1  M  NH,  HCOs, pH 8.0.  The molecules to be compared (e.g., all- 
14  3  14  Qa-2  and  C-H-2K~  were  then  mixed at  a  H:  C  ratio of 2-3:1  and  relyophilized. The 
lyophilized samples were dissolved in  1.0 ml 0.1  M  NH4HCOs,  pH 8.0, and  20 #g TPCK- 
trypsin was added. After a  1-h incubation at 37°C, additional trypsin (100-200 #g) was added 
and  the incubation was continued for  12-16 h  at  37°C.  The pH was then  lowered by the 
addition of 2-3 drops of glacial acetic acid and the sample was lyophilized. Before chromato- 
graphy, the peptides were solubilized in 2.0 ml 0.05 M pyridine acetate (PA), pH 3.13. Insoluble 
material was removed by centrifugation at 10,000 g for 5 min. Routinely 75-95% of the input 
cpm were recovered in the acid soluble fraction. Tryptic peptides were analyzed by cation 
exchange  chromatography  on  Teehnicon  chromobeads  type  P  (Technicon  T  &  T  Corp., 
McFaxland, Wis.), using a  3- ×  150-mm  microbore column maintained at 54°C by a  water 
jacket. The solubilized peptides were applied to the column in 0.05  M  PA, pH  3.13.  After 
washing the column with 5-6 ml of starting buffer, a  pH-ionic strength gradient was applied 
using a Varigard gradient maker (Phoenix Precision Instruments, Gardiner, N. Y.).  30 ml of 
each of the following PA buffers was used: 0.05 M, pH 3.13;  0.1 M, pH 3.54; 0.2 M, pH 4.02; 
0.5 M, pH 4.50;  2.0 M, pH 5.0.  After completion of the gradient, 2-3 ml of 2 N  NaOH was 
applied to remove all bound  material.  12  drop fractions were collected into minivials and 
allowed to evaporate. Water (0.35 ml) and scintillation fluid were added and the samples were 
counted. The  H  and 14C cpm were normalized and corrected for channel spillover. M. J.  SOLOSKI, J.  w.  UHR,  L.  FLAHERTY, AND E.  S.  VITETTA  1083 
Results 
Isolation of Qa-2 and H-2 Molecules.  The Qa-2 antigen is expressed on subpopulations 
of lymphocytes and  the  surface density is several-fold lower than  H-2D or  H-2K 
antigens, as determined by immunopreeipitation of radiolabeled molecules from cell 
lysates (15). Hence, it was important to obtain a population of lymphocytes that was 
enriched  for Qa-2 antigens.  Studies by Flaherty et al.  (11) have demonstrated that 
75-90% of the cells in populations of mitogen  (Con A, phytohemagglutinin  [PHA], 
LPS)-activated lymphocytes express serologically detectable Qa-2. Therefore, Con A- 
stimulated  spleen cells  were used  for preparation  of Qa-2  molecules.  An  SDS gel 
profile of a typical immunopreeipitate using extracts prepared from B6 Con A blasts 
is shown in Fig. 1A. As demonstrated earlier (15), B6. KlaB6 (aQa-2) serum recognizes 
a polypeptide of-44,000 mol wt. fl-2 microglobulin, which is known to be associated 
with Qa-2 molecules, was allowed to migrate  off the gel under the electrophoretic 
conditions employed. When glycoproteins pools from B6.K1  (Qa-2-)  Con A blasts 
were treated with og~.a-2, no peak corresponding to 44,000 mol wt is precipitated, 
thus establishing the specificity of our antisera (Fig.  1B). When glycoproteins from B6 
Con A blasts were precipitated with NMS, a significant amount of material migrating 
at 44,000 mol wt could also be detected. Thus radioactive material, presumably non- 
Qa-2 in nature, could contaminate our Qa-2 preparations and thereby interfere with 
subsequent structural analysis. Additional experiments demonstrated that the mate- 
rial that was nonspecifically precipitated could be significantly reduced by preincu- 
bating glycoprotein pools with NMS and S. aureus. Under the preclearing conditions, 
a maximum of 5-10% of the 44,000-mol wt peak could represent nonspecific contam- 
ination.  Sears et al. (27) reported a similar problem in their structural studies of the 
H-2L alloantigen,  and observed that  nonspecific precipitation  could be reduced by 
preincubating the lysate with NMS coupled to Sepharose. 
H-2K or  H-2D alloantigens  were immunoprecipitated  from  mitogen-stimulated 
B10.A  or  B6  spleen  cells.  Preliminary  experiments  revealed  that  the  preclearing 
regimen was applicable to the isolation of 1-1-2 gene products. The anti-H-2 sera used 
are complex and  contain  reactivities  toward  H-2K, D,  and  I  region  determinants 
(Table I). However, by selecting the appropriate recombinant congenic strain, specific 
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FIG.  1.  SDS-PAGE analysis  of an aQa-2 immunoprecipitate. Glycoprotein pools obtained from 
8H-arginine labelled B6(A) or B6.KI(B) Con A-activated spleen cells were precleared with KAMIg 
and NMS as described in Materials and Methods. Aliquots (approximately 2 ×  107 cell equivalents) 
of the precleared glycoprotein pool were removed and incubated with 30 #1 aQa-2 (  ) or NMS 
(-----). Immunoprecipitates were formed by the addition of GAMIg and subsequently were washed, 
solubilized, reduced, and analyzed on 12.5% polyacrylamide gels. 1084  STRUCTURAL  HOMOLOGY  BETWEEN  Qa-2  AND  H-2  ALLOANTIGENS 
for the K  or D  end antigens of the H-2 complex, specific immunoprecipitations  can 
be obtained.  For example, B10. D2otBl0. BR will contain reactivity toward determi- 
nants carried by K k, I-A  k, I-E/C k, and D k (Table I).  By using B10.A  (K  k, D d) cells, 
reactivity  is  confined  to  the  K  end.  Any  I  region-controlled  molecules  that  are 
coprecipitated can be readily separated from H-2 by SDS-polyacrylamide gel electro- 
phoresis (PAGE)  (see Fig. 2A and B). 
Do  Qa-2,  H2-K,  and  H2-D  Alloantigens  Exist  as  Separate  Molecules  in  NP-40 
Lysates?  The  next  series  of  experiments  addressed  the  question  of  whether  the 
alloantigens  detected  by anti-Qa-2  or anti-H-2  sera in detergent  lysates  of Con A- 
treated  B6 splenocytes  exist as separate  molecular species. The experimental  design 
was to remove all Qa-2 molecules from the lysate and then determine if H-2K b or H- 
2D  b molecules had been removed. Thus, glyeoprotein pools from [aH]arginine-labeled 
B6-Con  A  blasts  were  precleared  as  described  in  Materials  and  Methods.  The 
precleared extracts (~ 107 cell equivalents)  were then incubated with sufficient aQa-2 
(controls  received  equivalent  amounts  of  NMS)  to  ensure  removal  of  all  Qa-2 
molecules.  The  immune  complexes  thus  formed  were removed  by  the  addition  of 
affinity-purified  GAMIg  coupled  to  Sepharose.  This  immunoabsorbant  was  used 
because aQa-2  antisera do not react with S.  aureus. The Sepharose was removed by 
filtration and the sample was treated with appropriate alloantisera. 
The results of these experiments  are shown in Fig.  2.  Under conditions in which 
95-100%  of  the  Qa-2  was  removed  (Fig.  2E  and  F),  there  was  no  removal  of 
immunoprecipitable  H-2D b (Fig.  2C and D)  or H-2K b (Fig.  2A and B). This result 
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FIG.  2.  Effect of the removal of Qa-2 alloantigen  on the subsequent  isolation of H-2K b or H-2D b 
alloantigen.  Precleared  glycoprotein  ,l~ols  were  obtained  from  a  NP-40  lysate  of  [aH]arginine- 
labeled B6 Con A  blasts. Aliquots  (~ 10  cell equivalents)  were removed  and incubated  with  30 pl 
of aQa-2  or NMS.  Affinity-purified  GAMIg coupled  to Sepharose  was then added to remove any 
immune  complexes  that  had  formed.  The  Sepharose  was  then  removed  by  filtration  and  the 
b  b  remaining sample was reacted with 30 lal aK  (A and B), aD  (C and D), aQa-2  (E and F), or NMS 
((3  and  H).  Each  sample  was  then  precipitated  with  GAMIg  and  the  immunoprecipitate  was 
washed, solubilized, reduced,  and analyzed by SDS-PAGE. M. J. SOLDSKI, J.  W  UHR, L. FLAHERTY, AND E. S. VITETTA  1085 
confirms earlier studies by Michaelson et al. (15) and indicates that the H-2K, H-2D, 
and Qa-2 alloantigens reside on distinct molecular species. 
T~yptic Peptides of Isolated [~H]arginine-labeled Qa-2 Molecules.  Qa-2 molecules labeled 
with [Sill- or [Z4C]arginine  were isolated from B6-Con A  blasts  and digested with 
trypsin as described in Materials and Methods. Each digest was analyzed by cation 
exchange chromatography employing a  PA pH-ionic strength gradient. Fig. 3 (top) 
shows a peptide map in which [nH]arginine- and [14C]arginine-labeled Qa-2 were co- 
analyzed. 11-13 arginine peptides can be reproducibly resolved when Qa-2 molecules 
are digested and analyzed. The last peak in each map represents material eluted from 
the column by 2 N  NaOH. The amount of radioactivity recovered in this peak was 
variable and is not scored as a peptide in this analysis. Routinely 85-95% of the input 
radioactivity is soluble in the acidic (pH 3.13) starting buffer, and 85-95% of this acid 
soluble radioactivity is recovered from the column. Thus, the vast majority of arginine- 
labeled peptides are being detected by this analysis. It should be noted that the maps 
generated from [aH]arginine- or [14C]arginine-labeled Qa-2 are completely superim- 
posable. This finding demonstrates the reproducibility of the "double-label" mapping 
technique. The advantage of performing a  double-label analysis versus aligning pH 
gradients or internal markers in single-label experiments has been discussed previously 
(25). 
The  amount of radioactivity under the  majority of the peaks  is  approximately 
equal throughout the map (Fig. 3, top). The simplest interpretation of this observation 
is that these peptides are derived from a  single major molecular species.  However, 
several minor peaks are observed. The aQa-2 serum used was produced by immunizing 
B6.K1  mice  with  B6  spleen  and  lymph node  cells  (6).  Therefore,  this  serum  is 
potentially polyvalent with  reaetivities toward  Qa-2,  Qa-3,  Qa-4,  and  Qa-5  (13). 
Because reactivity toward Qa-4 and Qa-5 has only been observed using monoclonal 
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antibodies  (7),  the minor peaks observed  might  be  derived from a  44,000-mol  wt 
polypeptide bearing the Qa-3 alloantigen. Alternatively, because the majority of these 
minor  species  are  not  always  observed,  some  may  be  either  incomplete  trypsin 
digestion products or the result of occasional trypsin-mediated cleavages at tyrosine 
residues  (28).  Nevertheless,  these  minor  species  did  not  detract  from  our  studies 
because only major peaks were scored in the comparisons. In addition, one should 
note the large peak eiuting at fractions 135-140. We explored the possibility that this 
peak represents  free arginine by mixing [SH]arginine-labeled Qa-2  with free [14C]- 
arginine,  digesting  with  trypsin  and  analyzing the  products  by  cation  exchange 
chromatography. Free arginine co-chromatographed with the major Qa-2 peak (data 
not shown). This free arginine could have arisen  from background contamination 
carried over during the purification procedure, or alternatively could be generated by 
the  trypsin cleavage of adjacent  arg-arg or  lys-arg residues.  The  latter  possibility 
seems most likely because amino acid sequence analysis of H-2K, H-2D, and H-2L 
alloantigens indicate several sites in which such cleavages could occur (29-32). 
It is well documented that the technique of cation exchange chromatography used 
in  our experiments  is  very sensitive for detecting structural  differences (33-36).  A 
single  amino  acid  substitution  in  a  given  peptide  can  markedly alter  its  elution 
position from the column (34-36).  Hence, structurally distinct polypeptides should 
show little peptide homology. Fig. 3  (bottom)  shows a  peptide map comparison of 
Qa-2 with a mouse Ig r-chain isolated from the IgG2A~ secreted by P3 myeloma cells 
(37). None of the 12 Qa-2 peptides co-eluted with peptides derived from this r-chain. 
The  free  arginine  peptide  is  indicated  by  the  arrow.  This  result  confirms  that 
structurally unrelated molecules show little or no homology at the level of comparative 
peptide mapping. 
Comparison of the Arginine T~yptic Peptides of Qa-2 and H-2 Alloantigens.  Fig. 4 shows 
a  comparative  peptide  map  analysis  of Qa-2  and  H-2K  b  and  H-2D  b molecules. 
Clearly, Qa-2 is structurally distinct from H-2K  b and D b because numerous peptide 
differences are observed. However, there are several Qa-2 peptides that co-elute with 
peptides derived from H-2K  b or H-2D  b.  Thus,  5/12  (42%) and  2/12  (17%) of the 
Qa-2 peptides co-eluted with peptides derived from H-2K  b and H-2D  b, respectively. 
This level of peptide homology is similar to that reported for various H-2K, H-2D, 
and H-2L altoantigens when their tryptic peptides were compared (26, 27, 38). 
Because the Qa-2 and H-2 molecules compared above were isolated from the same 
mouse strain, it was of interest to determine whether Qa-2 molecules have demonstra- 
ble peptide homology with H-2 molecules from another haplotype. Fig. 5 shows the 
comparative  peptide  maps  of Qa-2  and  H-2K  k  or  H-2D  d.  Again,  considerable 
structural homology is observed with 4/12  (33%) and 5/12  (42%) Qa-2 peptides eo- 
eluting with H-2K  k and H-2D  d peptides, respectively. A summary of the peptide map 
comparisons of Qa-2 vs. H-2 alloantigens is shown in Table II. It should be noted that 
the major Qa-2 peak, which we have demonstrated to be free arginine, is not included 
in the peptide homology comparison of this study. 
The  majority of the coincident peaks  have similar ratios of aH:14C. This  is  the 
expected observation if the peaks are structurally identical (33,  38).  However a  few 
coincident  peaks  differ markedly in  their  aH:14C ratios  (for example,  Fig.  4,  top 
fractions 210-215, and Fig. 5, top fractions 170-175). We are including these peaks in 
the comparisons because we cannot exclude  ~  the possibility that a  given peak may M. J.  SOLOSKI, J.  W.  UHR,  L.  FLAHERTY,  AND  E.  S.  VITETTA  1087 
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FIG. 4.  Ion exchange chromatograph~" of the arginine-labeled tryptic peptides from Qa-2  and 
H-2  b alloantigens. Qa-2 labeled with [°H]arginine was compared to [14C]arginine-labeled H-2K  b 
(top), or H-2D  b (bottom) isolated from B6-Con A blasts. The arrows indicate peptides that co-elute. 
The bold arrow marks the position of the major Qa-2 peak, which was identified as free arginine. 
contain two or more peptides, one that is homologous, the other not. Indeed, the 
difference in the aH:14C ratio suggests that this is the case. 
A  third H-2 locus, H-2L,  which shares  public but  not private  specificities with 
H-2D  alloantigens, has  recently been  described  (39,  40).  Hence,  antisera  used  to 
immunoprecipitate H-2D molecules could also detect H-2L alloantigens. We believe 
that it is unlikely that this complexity affects comparisons between Qa-2 and H-2D 
antigens for the following reasons: (a) no H-2L  b alloantigen has yet been detected by 
immunoprecipitation (40);  (b)  the tryptic peptide map of H-2D  a (Fig. 5, bottom) is 
very similar to the maps reported by Sears et al. (27; Figs. 3 and 4) in which H-2D  a 
was  immunoprecipitated  using  an  antiserum  directed  against  an  H-2D  d  private 
specificity; and (c) previous tryptic peptide maps of samples containing both H-2D  a 
and H-2L  d showed that the H-2L  a molecule represented only a very small fraction of 
the total radioactivity (38). We conclude therefore that our H-2D antisera are largely 
recognizing private  H-2D  d or  H-2D  b determinants.  Any minor  peaks  that  could 
represent H-2L alloantigens were not included in the comparison. 
The tryptic peptide comparisons indicate that Qa-2 is structurally related to H-2K 
and  H-2D  alloantigens and  that  the  degree  of relatedness  is  equivalent  to  that 
observed among H-2 alloantigens (26, 27, 38). 
Peptide Map Comparison of Qa-2 and H-2K* Lysine-containing Peptides.  Fig. 6 shows a 
peptide map comparison of the lysine-labeled tryptic peptides derived from Qa-2 and 
H-2K  k. As observed with the arginine maps, Qa-2 is structurally distinct from H-2K  k. 
However, homologous peptides are again observed with 3/7 (43%) Qa-2 peptides co- 
eluting with H-2Kk-derived peptides. 1088  STRUCTURAL  HOMOLOGY  BETWEEN  Qa-2  AND  H-2  ALLOANTIGENS 
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FIG.  5.  Ion  exchange chromatography of the  arginine-labeled  tryptic  peptides  from Qa-2  and 
H-2  a alloantigens. Qa-2 labeled with [nH]arginine was compared with [14C]arginine-labeled H-2K  k 
(top)  or H-2D  d  (bottom)  isolated  from BI0.A LPS  blasts. The arrows indicate peptides that  co- 
elute. The bold  arrow  marks the position of the major Qa-2 peak, which was identified  as  free 
arginine. 
TABLE  II 
Average Peptide Homology between Qa-2 and H-2 Alloantigens 
H-2K b  H-2D b  H.2K k  H-2D d 
Qa-2  8  (33)  4  8  10  2-~  ~  (21)  ~  (30)  ~  (43) 
* Percentage of homology (numbers in parentheses) 
2 ×  number of peptides in common 
number ofQa-2 peptides +  number of H-2 peptides 
Discussion 
The present results at the primary structural level indicate that the Qa-2, H-2K  u, 
and H-2D  b alloantigens isolated from C57BL6/J mice are sufficiently distinct to show 
that the Qa-2 alloantigen is encoded by a separate locus. In addition, there is sufficient 
structural homology between Qa-2 and H-2 alloantigens to prove that they evolved 
from a common primordial gene. Previous serological studies demonstrated that the 
strain  and  tissue distribution  of Qa-2  antigens  are different from any known  H-2 
antigens, thereby suggesting that Qa-2 and H-2 alloantigens are encoded by different 
loci. Genetic evidence has mapped the Qa-2 locus to the Tla region, telomeric to H-2D 
(5). In addition, biochemical studies have shown that the determinants recognized by 
aQa-2 or all-2 alloantisera reside on separate molecular species (15; Fig. 2). However, M. J.  SOLOSKI, J. w.  UHR, L. FLAHERTY, AND E. S. VITETTA  1089 
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all of the above information cannot  formally exclude the possibility that  the Qa-2 
locus encodes for an enzyme that  modifies an  H-2 alloantigen post-translationally. 
Thus,  when  the  tryptic peptides  from Qa-2  and  H-2  alloantigens  are  compared, 
considerable structural variation is detected. Such extensive differences are not due to 
differences in  glycosylation, because glycopeptides are not  resolved in our analysis 
(34). The possibility that other modifications, such as methylation or acetylation of 
amino acids, could account for the structural  variation observed is highly unlikely 
because  such  extensive  modifications  are  unprecedented  (41,  42).  We  therefore 
conclude that the observed structural differences are due to variations in the amino 
acid sequence. This implies that the 44,000-mol wt Qa-2 polypeptide is encoded by a 
locus distinct from that encoding H-2K and H-2D. 
The comparative peptide mapping of Qa-2 antigen with several H-2 alloantigens 
has  shown  that  21-43%  of their arginine-labeled  tryptic peptides  are  homologous 
(Table II). This degree of structural homology is also observed when various H-2K, 
H-2D,  and  H-2L  alloantigens  are  compared  (26,  27,  38).  Because  we  have  no 
information on the size of these homologous peptides, it is possible that this homology 
represents  only  a  very  restricted  region(s)  of the  molecules.  However,  molecules 
showing  such  levels  of peptide  homology have  been  repeatedly  demonstrated  to 
exhibit 75-90% amino acid sequence homology (29-32). It is therefore possible that 
Qa-2 and H-2 alloantigens will show similar degrees of  amino acid sequence homology. 
This is the first observation that there exist genes in the Tla region that show primary 
structural homology to H-2K and H-2D gene products. 
Two general hypotheses have been developed to explain the presence of numerous 
structurally related loci on the 17th chromosome (43). The first postulates that these 
loci arose from duplications and subsequent  divergence of a  primordial gene. The 
alternative hypothesis states that  these loci were always separate but  the structural 
homologies are the result of convergent evolution due to common functional con- 
straints.  The finding that  there are at  least  four loci encoding structurally related 
gene products (H-2D, -K, -L, and Qa-2) and additional loci encoding other potentially 
homologous proteins (TL, Qa-1, etc.) argues against convergent evolution and thereby 
makes the duplication hypothesis more attractive. The observation that there are cell 
surface structures resembling Qa and TL antigens on guinea pig and human lympho- 
cytes suggests that the duplication event occurred before speciation (44-46). 
The Qa-2 and H-2 alloantigens share several biochemical properties. For example, 1090  STRUCTURAL  HOMOLOGY BETWEEN Qa-2 AND H-2 ALLOANTIGENS 
all bind ,8-2 microglobulin, all are glycosylated, and all are membrane proteins (47). 
In this regard, our comparisons have detected two Qa-2 peptides that appear to have 
an H-2-derived homologue in all alleles and loci tested. Hence, some of the homologies 
observed may represent regions of the molecule involved in glycosylation, membrane 
attachment, or interactions with ,8-2  microglobulin.  One would  predict, therefore, 
that the Qa-1  and TL antigens would also share primary structural homology with 
H-2 because these proteins possess similar biochemical features (16, 18, 47). 
There is abundant evidence that indicates that the T/t and H-2 complexes contain 
a  variety of loci that are implicated in cell-cell recognition. Our findings regarding 
Qa-2 alloantigen suggest that there is a cluster of genes in the Tla region that encodes 
gene products structurally resembling H-2 alloantigens.  It  is therefore tempting to 
speculate that Qa antigens may function on hematopoietic cells as immune recognition 
units similar to H-2K, H-2D, and H-2L. The recent finding that cytotoxie effector T 
cells can be generated against Qa-1 or Qa-2 alloantigens (48, 49) supports this idea. 
Summary 
The  Tla region located on the murine  17th chromosome controls several serolog- 
ically defined cell surface antigens. These antigens, referred to as Qa-1-5 and TL, are 
expressed on a  variety of hematopoeitic cell populations.  In the present studies we 
have immunoprecipitated isotopically labeled Qa-2 and H-2 molecules from mitogen- 
stimulated B6 spleen cells. Sequential immunoprecipitation experiments have shown 
that the determinants recognized by aQa-2, aH-2K  b, and aH-2D  b alloantisera reside 
on separate molecular species. Comparative mapping of the arginine-labeled tryptic 
peptides from Qa-2, H-2K  b, and H-2D  b molecules indicate that Qa-2 is structurally 
distinct  but  that  there  is  considerable  structural  homology;  21-43%  of the  Qa-2 
peptides co-chromatograph with peptides derived from H-2D  b and  H-2K  b, respec- 
tively. Similar levels of homology are observed when Qa-2 is compared with H-2K  k 
or H-2D  d. The results show that the Qa-2 alloantigen is encoded by a locus separate 
from the loci encoding H-2K or H-2D alloantigens, but that the Qa-2, H-2K, and H- 
2D alloantigens are sufficiently related at the primary structural level to indicate that 
they evolved from a common primordial gene. 
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